Department of Neurology, University Hospital of Ioannina, Ioannina, Greece;
Unit of Medical Technology and Intelligent Information System, Department of Materials Science and Engineering, University of Ioannina, Ioannina, Greece.
In Vivo. 2021 Jul-Aug;35(4):2327-2330. doi: 10.21873/invivo.12507.
Accurate assessment of symptoms in Parkinson's disease (PD) is essential for optimal treatment decisions. During the past few years, different monitoring modalities have started to be used in the everyday clinical practice, mainly for the evaluation of motor symptoms. However, monitoring technologies for PD have not yet gained wide acceptance among physicians, patients, and caregivers. The COVID-19 pandemic disrupted the patients' access to healthcare, bringing to the forefront the need for wearable sensors, which provide effective remote symptoms' evaluation and follow-up.
We report two cases with PD, whose symptoms were monitored with a new wearable CE-marked system (PDMonitor), enabling appropriate treatment modifications.
Objective assessment of the patient's motor symptoms in his daily home environment is essential for an accurate monitoring in PD and enhances treatment decisions.
准确评估帕金森病（PD）患者的症状对于做出最佳治疗决策至关重要。在过去的几年中，不同的监测方式已开始在日常临床实践中使用，主要用于评估运动症状。然而，PD 的监测技术尚未在医生、患者和护理人员中得到广泛认可。COVID-19 大流行使患者无法获得医疗保健，这凸显了对可穿戴传感器的需求，这些传感器可提供有效的远程症状评估和随访。
我们报告了两例 PD 患者的病例，他们的症状通过一种新型的经 CE 标记的可穿戴系统（PDMonitor）进行监测，从而能够对治疗进行适当的调整。
在 PD 中，对患者日常居家环境中运动症状的客观评估对于准确监测至关重要，并有助于治疗决策。
